• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

高碘酸氧化-还原胺化法对尿酸酶的聚乙二醇化研究

陈阳建, 陈新齐, 郑祥云, 宋潇达

陈阳建, 陈新齐, 郑祥云, 宋潇达. 高碘酸氧化-还原胺化法对尿酸酶的聚乙二醇化研究[J]. 中国药科大学学报, 2015, 46(3): 364-370. DOI: 10.11665/j.issn.1000-5048.20150318
引用本文: 陈阳建, 陈新齐, 郑祥云, 宋潇达. 高碘酸氧化-还原胺化法对尿酸酶的聚乙二醇化研究[J]. 中国药科大学学报, 2015, 46(3): 364-370. DOI: 10.11665/j.issn.1000-5048.20150318
CHEN Yangjian, CHEN Xinqi, ZHENG Xiangyun, SONG Xiaoda. Research on PEGylated uricase by periodate oxidation and reductive- amination[J]. Journal of China Pharmaceutical University, 2015, 46(3): 364-370. DOI: 10.11665/j.issn.1000-5048.20150318
Citation: CHEN Yangjian, CHEN Xinqi, ZHENG Xiangyun, SONG Xiaoda. Research on PEGylated uricase by periodate oxidation and reductive- amination[J]. Journal of China Pharmaceutical University, 2015, 46(3): 364-370. DOI: 10.11665/j.issn.1000-5048.20150318

高碘酸氧化-还原胺化法对尿酸酶的聚乙二醇化研究

基金项目: 宁波市自然科学基金资助项目(No.2014A610208);浙江省大学生科技创新活动计划暨新苗人才计划项目(No.2014R433003)

Research on PEGylated uricase by periodate oxidation and reductive- amination

  • 摘要: 采用高碘酸氧化-还原胺化法对尿酸酶的N端氨基进行聚乙二醇修饰研究。首先,以相对分子质量为20 kD的单甲氧基聚乙二醇氨基盐酸盐(mPEG20000-NH2·HCl)和N-叔丁氧羰基-L-丝氨酸(Boc-Ser-OH)为原料通过酰胺化反应制备聚乙二醇中间体,然后由三氟乙酸(TFA)作用脱去Boc基团获得目标产物Ser-mPEG20000,该化合物经高碘酸钠氧化生成具有较高活性的聚乙二醇醛类衍生物,经超滤处理后即可用于蛋白质N端氨基的定点修饰,并对其修饰尿酸酶的条件进行了优化。聚乙二醇中间体和目标产物的结构通过IR和1H NMR进行表征,目标产物的总收率达72.8%。对尿酸酶的初步修饰研究表明,化合物Ser-mPEG20000具有较好的修饰蛋白的能力,对尿酸酶的最佳修饰条件为:Ser-mPEG20000与尿酸酶物质的量比为2∶1,在溶液pH 5.0条件下,于25 ℃反应6 h。
    Abstract: PEGylated uricase was prepared with the N-terminal amino site-specific modification by periodate oxidation followed by reductive-amination. A monomethoxy poly(ethylene glycol)intermediate was synthesized by amidation from monomethoxy poly(ethylene glycol)amine hydrochloride 20000(mPEG20000-NH2 ·HCl)with the relative molecular mass of 20 kD and N-(tert-butoxycarbonyl)-L-serine(Boc-Ser-OH), and then the Boc group of the intermediate was removed by trifluoroacetic acid(TFA)to produce the desired product Ser-mPEG20000. This compound could be oxidated by periodate to obtain a new poly(ethylene glycol)aldehyde derivative with high activity, which could be used to modify proteins with the N-terminal amino site-specific PEGylation after ultrafiltration, and the modification conditions to uricase by Ser-mPEG20000 were optimized. The structures of poly(ethylene glycol)intermediate and the target product were characterized by IR and 1H NMR, and the overall yield of the target product was 72. 8%. The preliminary modification to uricase indicated that the desired product Ser-mPEG20000 could modify proteins easily and efficiently. The optimal modification conditions of uricase PEGylated by Ser-mPEG20000 were obtained as follows: the molar ratio of Ser-mPEG20000 to uricase was 2 ∶1; the pH value of solution was 5. 0; the reaction temperature was 25 °C and the reaction time was 6 h.
  • [1] Duncan R.Polymer therapeutics as nanomedicines:new perspectives[J]. Curr Opin Biotechnol,2011,22(4):492-501.
    [2] Tian H,Yao WB.Advances in PEGylation in drug delivery systems[J]. J China Pharm Univ(中国药科大学学报),2008,39(4):379-384.
    [3] Zhou LJ,Liu JP,Xiong F,et al.Perparation and in vitro evaluation of PEG-coated superparamagnetic iron oxide nanoparticles[J].J China Pharm Univ(中国药科大学学报),2013,44(4):316-320.
    [4] Pasut G,Veronese FM.State of the art in PEGylation:the great versatility achieved after forty years of research[J]. J Control Release,2012,161(2):461-472.
    [5] Li WJ,Zhan P,Clercq ED,et al.Current drug research on PEGylation with small molecular agents[J]. Prog Polym Sci,2013,38(3/4):421-444.
    [6] Alconcel SNA,Baas AS,Maynard HD.FDA-approved poly(ethylene glycol)-protein conjugate drugs[J]. Polym Chem,2011,2(7):1442-1448.
    [7] Veronese FM,Pasut G.PEGylation:posttranslational bioengineering of protein biotherapeutics[J]. Drug Discov Today Technol,2008,5(2/3):57-64.
    [8] Gonzalez M,Vaillard SE,Grau RJ.Pegylation:an overview and recent advances reported in the patent literature[J]. Recent Patents Chem Eng,2011,4(3):241-264.
    [9] Li YC,Zhu S,Gao XD,et al.Research on N-terminal site-specific PEGylated uricase[J]. Pharm Biotech(药物生物技术),2009,16(6):508-511.
    [10] Sherman MR,Saifer MGP,Perez-Ruiz F.PEG-uricase in the management of treatment-resist ant gout and hyperuricemia[J]. Adv Drug Deliv Rev,2008,60(1):59-68.
    [11] Dong HX,Tong Y,Qian XW,et al.Site-specific PEGylation strategies for proteins and peptides[J]. Pharm Clin Res(药学与临床研究),2013,21(4):360-365.
    [12] Gonzalez M,Vaillard SE.Evolution of reactive mPEG polymers for the conjugation of peptides and proteins[J]. Curr Org Chem,2013,17(9):975-998.
    [13] Geoghegan KF,Stroh JG.Site-directed conjugation of nonpeptide groups to peptides and proteins via periodate oxidation of a 2-amino alcohol.Application to modification at N-terminal serine[J]. Bioconjugate Chem,1992,3(2):138-146.
    [14] Gaertner HF,Offord RE.Site-specific attachment of functionalized poly(ethylene glycol)to the amino terminus of proteins[J]. Bioconjugate Chem,1996,7(1):38-44.
    [15] Sun JJ,Song XD,Tian H,et al.Synthesis of a novel histidine-targeting poly(ethylene glycol)and modification of lysozyme[J]. J Appl Polym Sci,2011,119(4):2183-2188.
    [16] Ye YQ,Ding B,Wang K,et al.Determination of the degree of substitution at secondary hydroxyls of hydroxypropyl guar gum by periodate oxidation[J]. Chem J Chin Univ(高等学校化学学报),2009,30(4):835-840.
    [17] Wen JH,Cai XM.Inference on oxide product of periodic acid or tetraacetate lead to adjacent hydroxyl compound[J]. J Jinzhong Univ(晋中学院学报),2011,28(3):33-37.
    [18] Clamp JR,Hough L.The periodate oxidation of amino acids with reference to studies on glycoproteins[J]. Biochem J,1965,94:17-24.
计量
  • 文章访问数:  1609
  • HTML全文浏览量:  26
  • PDF下载量:  1240
  • 被引次数: 0
出版历程
  • 刊出日期:  2015-06-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭